Microsoft enters mid-May in an unusual spot: the stock is essentially flat on the week, the quarter's results are already behind it, and yet options traders are showing the most defensive posture seen in months.
The options market is the standout signal this week. The put/call ratio jumped to 0.50 on Tuesday — well above its 20-day average of 0.37, and nearly three standard deviations from the mean. That z-score of 2.81 is rare. For a mega-cap with typically call-heavy flow, this level of hedging demand stands out. The 52-week high on the PCR is 0.85, so the move isn't at an extreme, but the speed of the spike — from 0.35 the prior day — is notable in itself.
That caution follows a bruising earnings reaction. Microsoft's Q3 results, reported April 29, sent the stock down 5% the next day. It has yet to fully recover, still down roughly 1% on the week at $407.77, even after rallying 10% over the past month from its April lows. The results themselves were strong — Azure revenue grew 39% year-on-year, and the most recent quarterly numbers show an EBITDA margin near 60% and net income of $27.7 billion on $77.7 billion in revenue. The selloff was about multiples, not the business.
Short interest offers little drama here. Shorts actually retreated after the earnings print: SI % of FF dropped 7% over the past week to just 1.06% of the free float — roughly 78.5 million shares. Cost to borrow is near the floor at 0.26%, and availability in the lending market is ample. This is not a stock where bears are pressing aggressively. The ORTEX short score of 29.5 has barely moved over the past two weeks, and at the 79th percentile of its own history on the short-score rank, there's no evidence of a crowded short thesis building.
The analyst community remains firmly constructive, though a split emerged post-earnings. The majority raised targets — Tigress lifted to $680, Bernstein to $646, Wells Fargo to $625, and Citi to $620 — all maintaining positive ratings. A smaller group trimmed: Evercore cut from $580 to $510, and Barclays moved from $600 to $545, both keeping Overweight. On balance, the consensus mean target of $562 implies roughly 38% upside from current levels. Wedbush's Dan Ives reiterated Outperform with a $575 target as recently as today. The bear case from the Street is not about the business model — it is about capital expenditure intensity and whether AI infrastructure spending delivers returns fast enough to justify the multiple. The P/E of 23x (trailing) looks reasonable for the growth rate, but the TTM P/E based on the latest quarterly annualised figures is considerably higher, reflecting the premium priced in for the AI cycle.
The institutional base remains a picture of orderly accumulation. Vanguard and BlackRock together hold nearly 18% of shares, and the most recent filings show both adding. Among correlated peers, the week has been rougher: HUBS fell 27% over five days and CRM dropped 8%, while SAP gave back nearly 5%. Microsoft's relative resilience — barely down on the week while the peer group sold off hard — suggests some rotation toward quality within the software bucket.
The next scheduled earnings date is July 30. Between now and then, the watch is whether that PCR spike proves transient or whether options positioning stays elevated, and whether the Azure growth rate — the single number the Street is most focused on — is confirmed by any cloud data points from competitors reporting in the interim.
See the live data behind this article on ORTEX.
Open MSFT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
